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Neuropsychological and emotional correlates
of personality traits in Parkinson’s disease
Janneke Koertsa,b,∗, Lara Tuchaa, Klaus L. Leendersb and Oliver Tuchaa
aDepartment of Clinical and Developmental Neuropsychology, University of Groningen, Groningen, The
Netherlands
bDepartment of Neurology, University Medical Center Groningen, University of Groningen, Groningen, The
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Abstract. Parkinson’s disease (PD) is, apart from the well-known motor symptoms, also characterized by neuropsychological and
emotional disturbances. However, patients also often present with a personality profile of low Novelty Seeking and high Harm
Avoidance. This profile can be identified as the disease emerges, which raises the question whether these traits correlate with
more fundamental neuropsychological and emotional disturbances. This study determined the neuropsychological and emotional
correlates of Novelty Seeking, Harm Avoidance and two other personality traits that are often considered in PD, i.e. Reward
Dependence and Persistence.
Forty-three patients and 25 healthy participants were assessed with the Temperament and Character Inventory, a symptoms of
depression questionnaire and neuropsychological tests.
PD patients showed a higher Harm Avoidance than healthy participants, which was predicted by symptoms of depression. Groups
did not differ regarding Novelty Seeking, Reward Dependence and Persistence. While cognitive flexibility was a predictor of
Reward Dependence, Persistence was predicted by divergent thinking and inhibition. Novelty Seeking was not predicted by
cognition or emotion.
In conclusion, cognition and emotion are selectively related to personality traits in PD. Whereas Harm Avoidance covaries with
emotional symptoms, Persistence and Reward Dependence are related to cognition. Alterations in personality, cognition and
emotion in PD are thus not independent from each other.
Keywords: Novelty seeking, harm avoidance, executive functions, depression, Parkinson’s disease
1. Introduction
Parkinson’s disease (PD) is a progressive neurode-
generative disease that is characterized by motor symp-
toms and non-motor symptoms, such as depression
and cognitive impairments in the domains of execu-
tive functions, memory and psychomotor speed [1–5].
Since the first half of the 20th century, however, it was
repeatedly suggested that PD is also associated with
a typical (premorbid) personality profile of inflexibil-
ity, cautiousness, industriousness and low impulsivi-
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Developmental Neuropsychology, University of Groningen, Grote
Kruisstraat 2/1, 9712 TS Groningen, The Netherlands. Tel.: +31
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ty [6]. Recently, Poletti andBonuccelli [6] published an
overviewof the research examining personality traits in
patients with PD and concluded that, in contrast to what
was previously expected, there is no robust support for a
characteristic premorbid personality profile in patients
with PD. This lack of support is caused by the fact that
it is difficult to assess premorbid personality traits with
current test instruments. Furthermore, studies used dif-
ferent instruments for the measurements of personality
traits and revealed only conflicting results. Poletti and
Bonuccelli did however report that once PD emerges
patients show two typical personality traits [6]. First,
PD patients have often been described as “low Novelty
Seekers”, i.e. they prefer to stay with familiar routines,
are orderly, disciplined, reserved and controlled, have
a preference for saving and spending according to bud-
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gets and require considerable time when making de-
cisions [7]. Second, PD patients have been character-
ized by high levels of Harm Avoidance. According to
this trait, PD patients have been described as inhibited,
tense, pessimistic, easily tired and slow to recuperate
from physical exertion [7]. Further personality traits
that have been studied in PD are Reward Dependence
(i.e. the tendency to respond to signals of reward (e.g.
social approval) and the maintenance of behavior that
was previously associated with reward or relief of pun-
ishment) [7] and Persistence (i.e. the ability to contin-
ue, expect and seek reward, even when the expected
outcome is not always or only rarely successful) [8].
However, no specific profiles could be detected in PD
patients with regard to these traits [6].
Since no premorbid personality profile was found
in patients with PD, it appears that patients change in
personality (i.e. low Novelty Seeking and high Harm
Avoidance) as the disease emerges or evolves. This,
however, raises the question whether these person-
ality traits can be understood as changes associat-
ed with more fundamental neuropsychological impair-
ments and emotional disturbances, which are already
present in newly diagnosed patients with PD [4]. Stud-
ies reported cognitive impairments in about 30% of
newly diagnosed patients [4] which primarily affect
executive functions and psychomotor speed. Execu-
tive functioning is an umbrella term encompassing dif-
ferent functions which are needed in non-routine sit-
uations including cognitive flexibility, inhibition and
planning [9]. Based on the descriptions of Novelty
Seeking and Harm Avoidance as mentioned above, one
could expect that Novelty Seeking is related to execu-
tive functions and psychomotor speed, whereas Harm
Avoidance is associated with symptoms of depression
and performance of tests of executive functions (i.e.
inhibition). The aim of this study was to investigate the
neuropsychological and emotional correlates of Novel-




Patientswere randomly selected from thePDpatients
visiting the Movement Disorders outpatient clinic of
the Department of Neurology of the University Medi-
cal Center Groningen (UMCG), The Netherlands. All
selected patients were contacted by the researcher (JK)
Table 1
Descriptive and disease characteristics of PD patients (n = 43) and
healthy participants (n = 25)
PD patients Healthy participants
M (SD) M (SD)
Age (years) 63.6 (8.8) 62.8 (11.5)
Education∗ 5.3 (1.1) 4.8 (0.7)
Gender (female/male) 19/24 14/11
MMSE total 27.5 (1.5) 27.6 (1.2)
Disease duration (years) 5.3 (4.2)
UPDRS, part III 24.6 (8.8)
H&Y 2.2 (0.6)
LEDD 583.7 (435.7)
∗Dutch education scale ranging from 1 (elementary school not fin-
ished) to 7 (university degree); MADRS=Montgomery-Åsberg De-
pression Rating Scale; MMSE = Mini Mental State Examination;
UPDRS=Unified Parkinson’s Disease Rating Scale; H&Y=Hoehn
and Yahr scale; LEDD= Levodopa Equivalent Daily Dose.
and provided with information about this study. Forty-
three out of 74 PD patients agreed upon participation
and all signed an informed consent prior to study in-
clusion. Reasons for rejection of participation includ-
ed time constraints (n = 11), disinterest in supporting
research (n = 12) and a poor health condition (n = 8).
Patients were diagnosed with idiopathic PD accord-
ing to the criteria of the UK Parkinson’s Disease Soci-
ety Brain Bank. The motor severity of symptoms was
assessed with the Unified Parkinson’s Disease Rating
Scale [10] and the Hoehn and Yahr scale (H&Y) [11].
A Levodopa Equivalent Daily Dose (LEDD) was cal-
culated for all patients [12]. Patients were assessed in
their regular on-state following medication.
Healthy participants were recruited from the Gronin-
gen community throughword-of-mouthor were related
to other participants. The same procedurewas followed
as in patients. Twenty-five healthy participants agreed
upon participation and signed an informed consent pri-
or to study inclusion. Level of education was rated for
all participants with a Dutch education scale, ranging
from 1 (elementary school not finished) to 7 (univer-
sity degree). Groups did not differ in age (t = 0.30;
p = 0.76), gender (Chi-Square = 0.88; p = 0.35) and
education level (Z = −1.58; p = 0.11). Descriptive
and disease characteristics of PD patients and healthy
participants are reported in Table 1. Exclusion criteria
were dementia (MMSE< 24) [13], neurological disor-
ders other than idiopathic PD, co-morbidities accord-
ing to medical records of patients, deep brain stimula-
tion and the use of drugs (other than anti-parkinsonian
drugs) known to influence cognition. PD patients with
a clinical depression according to the criteria of Leen-
tjens et al. [14] were not excluded from the present
study. This study was approved by the medical ethical
committee of the UMCG.
J. Koerts et al. / Neuropsychological and emotional correlates of personality traits in Parkinson’s disease 569
2.2. Measures
2.2.1. Personality questionnaire
Personality characteristics of participants were as-
sessed with a shortened version of the Temperament
and Character Inventory (TCI-125) [15]. The TCI-125
is a true/false questionnaire which is based on the Psy-
chobiological Model of Temperament and Character of
Cloninger et al. [8]. Seven personality traits are mea-
sured, including Novelty Seeking, Harm Avoidance,
Reward Dependence, Persistence, Self-Directiveness,
Cooperativeness and Self-Transcendence. The present
study focuses only on Novelty Seeking, Harm Avoid-
ance, Reward Dependence and Persistence which have
been shown to be the most relevant personality traits
with regard to PD.
2.2.2. Symptoms of depression questionnaire
Symptoms of depression were assessed with the
Montgomery-Åsberg Depression Rating Scale
(MADRS) [16]. This scale contains items that mea-
sure affective symptoms (e.g. reported sadness and pes-
simistic thoughts) as well as items measuring somatic
symptoms (e.g. reduced sleep and lassitude) and cog-
nitive symptoms (e.g. concentration difficulties) of de-
pression.
2.2.3. Tests of executive functions
Several standardized, reliable and valid neuropsy-
chological test measures of executive functions were
applied in this study [9].
The Stroop Color Word Test [17] is used to assess
the ability of a person to maintain a goal in mind and to
suppress a habitual response in favor of a less familiar
one (i.e. inhibition). This test contains three cards, the
Word card, the Color card and the Color-Word card.
The target measure for inhibition is the Color-Word
card. This task requires participants to suppress the au-
tomatic tendency to read, while naming the color of
words that are themselves color names. The perfor-
mance was corrected for psychomotor speed, by divid-
ing the time needed for the Stroop Color-Word card by
the time needed for the Stroop Color card.
Cognitive flexibility was assessed with the Trail
Making Test [18] which consists of two parts. Part A
requires participants to draw a line, as fast as possible,
between numbers in ascending order. In part B, num-
bers and letters are used and participants need to switch
attention between both concepts: they have to draw a
line between both types of stimuli in ascending order,
alternating between numbers and letters and also as fast
as possible. The target measure for cognitive flexibility
was the performance on part B.
The Odd Man Out [19] was also used to measure
cognitive flexibility. This test requires participants to
indicate which shape, out of a set of four shapes, is
different. Three selection rules are possible and two
sets of twelve cards are used. For each set of cards
participants have to specify a different rule and both sets
are alternated four times. The total number of incorrect
responses is calculated.
The Digit Span Backward of the Wechsler Memory
Scale–Revised [20] was used to assess verbal working
memory. A series of digits are read to the participants
who are required to repeat the digits in the reverse order.
Semantic and phonemic verbal fluency tests were
used to evaluate divergent thinking. The semantic ver-
balfluency test requires participants to produce asmany
animals or professions as possible, each within a time
interval of one minute. Participants are not allowed to
name the same word twice. The total number of cor-
rectly produced animals and professions is registered.
During the phonemic verbal fluency test, participants
are asked to produce as many words as possible within
one minute starting with the letters D, A or T [21,22].
This verbal fluency test is equivalent to the FAS-test as
devised by Benton and deHamser [23]. Participants are
not allowed to name the same word twice or to produce
names of persons or towns. The total number of correct-
ly producedwords starting with D, A and T were calcu-
lated and combined into one phonemic verbal fluency
score.
The Zoo-Map of the Behavioral Assessment of the
Dysexecutive Syndrome [24] was used to assess plan-
ning. Participants were required to plan a route through
a zoo visiting previously specified attractions and fol-
lowing a set of rules. The test consists of two parts. The
first part is presented as an unstructured situation, par-
ticipants are not provided with information that could
help planning a route and only the attractions that need
to be visited and the rules are presented. In contrast,
part two is structured. An action plan which needs to
be followed is provided in addition to the same set of
rules as in part one. Both parts are rated by calculating
the total number of correctly visited attractions minus
errors (e.g. visiting attractions that were not previously
specified, not obeying the rules).
Finally the Frontal Assessment Battery which as-
sesses different executive functions, including concep-
tualization, cognitive flexibility, motor programming,
sensitivity to interference and inhibitory control was
used [25]. Each subtest is scored between 0 and 3. A
total score is calculated by adding the scores on the
different subtests.
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Table 2
Scores of PD patients (n = 43) and healthy participants (n = 25) on Novelty Seeking, Harm Avoidance, symptoms
of depression questionnaire as well as tests of executive functions and psychomotor speed
PD patients Healthy participants t p d
M (SD) M (SD)
Personality
Novelty Seeking 8.2 (2.5) 7.4 (2.3) 1.24 0.22 0.33
Harm Avoidance 10.7 (4.2) 8.4 (4.2) 2.13 0.04∗ 0.55
Reward Dependence 8.6 (2.7) 9.2 (2.4) −0.90 0.37 0.23
Persistence 2.5 (1.4) 2.2 (1.6) 0.71 0.48 0.20
Executive functions
FAB 15.2 (2.5) 17.4 (0.9) −5.17 < 0.001∗∗∗ 1.06
Stroop interference index 1.7 (0.3) 1.6 (0.2) 1.42 0.16 0.37
Trail Making Test B 127.2 (58.1) 102.6 (68.4) 1.58 0.12 0.40
OMO 5.2 (5.6) 1.2 (1.4) 4.42 < 0.001∗∗∗ 0.88
Digit Span backward 5.6 (2.1) 6.1 (1.4) −1.01 0.32 0.27
BADS Zoo map 2.4 (1.2) 2.8 (0.9) −1.49 0.14 0.36
Semantic fluency
–Animals 20.9 (5.4) 21.6 (4.4) −0.58 0.57 0.14
–Professions 15.0 (4.4) 17.5 (3.8) −2.42 0.02∗ 0.60
Letter fluency 38.7 (14.9) 38.6 (10.5) 0.01 0.99 0.00
Psychomotor speed
Trail Making Test A 52.3 (19.1) 42.1 (28.0) 1.78 0.08 0.45
Stroop Word Card 51.3 (12.5) 50.8 (11.4) 0.17 0.86 0.04
Depression
MADRS 9.2 (7.1) 2.3 (2.1) 4.80 < 0.001∗∗∗ 1.19
∗  0.05; ∗∗  0.01; ∗∗∗  0.005. BADS = Behavioral Assessment of the Dysexecutive Syndrome; FAB =
Frontal Assessment Battery; MADRS =Montgomery-Åsberg Depression Rating Scale; OMO= Odd Man Out.
2.2.4. Tests of psychomotor speed
The time needed for completion of Part A of the Trail
Making Test [18] and of the Stroop Word Card [17]
were used as a measure of psychomotor speed.
2.3. Statistical analyses
PredictiveAnalytic SoftWare (PASW) 18.0 was used
for statistical analyses. To compare PD patients and
healthy control participants with regard to Novelty
Seeking, Harm Avoidance, Reward Dependence, Per-
sistence, as well as executive functions, psychomotor
speed and symptoms of depression, t-tests for indepen-
dent samples were used. Furthermore, patients’ per-
formances in tests of executive functioning and psy-
chomotor speed were compared to normative data as
provided by the authors of tests applied or the authors
of published normative datasets as used in clinical prac-
tice [9]. In accordance with the new diagnostic crite-
ria for mild cognitive impairment in PD of the Move-
ment Disorders Society Task Force a cognitive test
performance was classified as “being impaired” when
the standard score was 1–2 standard deviations below
the mean [26]. Subsequently, it was calculated on how
many tests of executive functions as well as on how
many tests of psychomotor speed patients showed im-
pairments. With regard to the symptoms of depres-
sion, patients were classified as clinically depressed or
non-depressed according to the criteria of Leentjens et
al. [14].
Multiple linear regression analyses (method: step-
wise) were performed in the group of PD patients to de-
termine the unique contributionof symptomsof depres-
sion, executive functions, psychomotor speed and dis-
ease characteristics of PD (i.e. disease duration, H&Y
score, UPDRS part III score and LEDD) to Novelty
Seeking,HarmAvoidance, RewardDependenceor Per-
sistence. A p-value of  0.05 was considered signifi-
cant.
3. Results
PD patients showed significantly higher scores on
Harm Avoidance than healthy control participants. No
differences were found between these groups with re-
gard to Novelty Seeking, Reward Dependence and Per-
sistence (Table 2). With regard to cognition, PD pa-
tients performed significantly worse than healthy par-
ticipants on measures of executive functioning includ-
ing the Frontal Assessment Battery, a semantic fluen-
cy test (i.e. professions) and the Odd Man Out. Fur-
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thermore, PD patients reported more symptoms of de-
pression than healthy control participants and 19% of
patients (n = 8) were classified as clinically depressed.
The comparison of patients’ test performance with
normative data revealed that 74% of patients showed
impairments in executive functioning. While 21% of
patients (n = 9) showed an impairment in one test
measuring executive functions, 21% (n = 9) displayed
impairments on two test measures,9% (n = 4) on three,
5% (n = 2) on four, 16% (n = 7) on five and 2% (n =
1) on all testmeasures applied. Regarding psychomotor
speed, the results showed that 54% of patients showed
impairments on one or two tests of psychomotor speed.
The remaining 46% of patients showed no impairments
in this domain.
The results of the multiple regression analyses
showed that performances on tests of executive func-
tions and psychomotor speed as well as symptoms of
depression and disease characteristics did not predict
Novelty Seeking in PD patients. Harm Avoidance was,
however, significantly predicted by the symptoms of
depression (i.e. score on the MADRS; R2 = 0.20, F =
8.97, p = 0.005). Furthermore, while the performance
on part B of the Trail Making Test represented a signifi-
cant predictor of Reward Dependence (R2 = 0.13,F =
5.48, p = 0.03), Persistence was significantly predict-
ed by semantic fluency performance (i.e. professions)
and the Stroop interference index (R2 = 0.27, F =
6.46, p = 0.004), explaining 15% and 12% of variance
respectively.
4. Discussion
The results of the present study suggest that alter-
ations of cognition, emotion and personality in patients
with PD are not independent from each other. This
is in accordance with previous findings demonstrat-
ing that cognition and emotion sub-serve personality
traits in patients with other neurodegenerative disor-
ders, including fronto-temporal dementia, Alzheimer’s
disease, dementia with Lewy bodies and progressive
supranuclear palsy [27]. However, the results of the
present study also indicate that there are selective ef-
fects of emotion and cognition on personality in PD.
While some personality traits are associated with cog-
nition but not emotion, others have been shown to be
related with emotion but not cognition.
With regard to emotion, an association was found be-
tween symptoms of depression in PD and Harm Avoid-
ance but not with Novelty Seeking, Reward Depen-
dence and Persistence. The present sample of PD pa-
tients scored significantly higher on Harm Avoidance
and reported significantly more symptoms of depres-
sion than healthy control participants, with a clinical
but mild depression being present in 19% of patients.
A relation between PD and affective disorders has often
been reported [28–30] with prevalence rates of depres-
sion ranging between 30 and 35% [31]. Higher levels of
Harm Avoidance suggest that PD patients are more in-
hibited and tense (even in normal circumstances), wor-
ry frequently, are pessimistic, negative and recuperate
slower fromphysical exertion and emotional stress than
healthy individuals [7]. Indeed, other studies focus-
ing on PD [32,33] and studies performed on the gener-
al population [34–36] also revealed that Harm Avoid-
ance has a strong association with depression and anx-
iety. The nature of the relation between Harm Avoid-
ance and affective disorders in PD is however not clear.
One could consider that Harm Avoidance represents a
personality trait of PD patients. However, since affec-
tive disorders do not necessarily follow the progres-
sive neurodegenerative course of PD and because af-
fective disorders can sometimes be successfully treated
in PD [38], one can also argue that Harm Avoidance is
not a personality trait but state dependent instead [6].
The relation between Harm Avoidance and depression
in PD thus needs further exploration in future studies.
Regarding cognition, significant associations were
found with Persistence and Reward Dependence, but
not with Harm Avoidance and Novelty Seeking. The
present sample of PD patients was characterized by fre-
quent cognitive impairments and significant deficits in
the domain of executive functions (i.e. Frontal Assess-
ment Battery), including divergent thinking (i.e. fluen-
cy professions) and cognitive flexibility (i.e. Odd Man
Out). However, even though Persistence and Reward
Dependence are both personality traits that are associat-
ed with cognitive functioning in PD, the present as well
as previous studies [40–43] indicate that these traits are
not specific for PD, because PD patients did not differ
from healthy participants in these traits. Nevertheless,
lower levels of Persistence in PD were associated with
difficulties in divergent thinking and the ability to in-
hibit behavior. This might indicate a complex interac-
tion between cognition and Persistence, which might
be explained by the attributes ascribed to low Persis-
tence. Cloninger [8] described individuals with low
Persistence as being changeable, irresolute and easily
discouraged as well as having difficulties with goal-
oriented behavior. While the latter three characteris-
tics are considered to be detrimental for performance,
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changeability can also be a beneficial feature. There are
many situations in which a change of behavior would
be more beneficial and adaptive to situational demands,
e.g. in situations with rapidly changing reward contin-
gencies [44]. Therefore it is not surprising that both a
better ability to inhibit behavior (i.e. enabling change-
ability) as well as difficulties in divergent thinking (i.e.
hampering goal-directedness and resoluteness) are as-
sociated with low Persistence.
Reward Dependence was associated with cognitive
flexibility (i.e. Trail Making Test part B), with diffi-
culties in cognitive flexibility being related to high-
er levels of Reward Dependence. This association ap-
pears reasonable considering that flexibility in general
is a crucial component of independence. People with
high levels of Reward Dependence who are sensitive
to emotional cues, responsive to social pressure as well
as crave for gratification may therefore be less inde-
pendent and depend more on the social support of oth-
ers [7]. The relation between Reward Dependence and
cognitive flexibility might also be explained in terms of
the brain structures involved in their processing. Re-
search on healthy individuals [45] as well as PD pa-
tients [46] revealed that both the striatum and the pre-
frontal cortex are involved in cognitive flexibility. In-
deed, recent imaging studies demonstrated that these
structures are relevant for Reward Dependence with
Reward Dependence being associated with connectiv-
ity in the white matter of the frontal lobe and with the
strength of the relative connectivity between the stria-
tum and prefrontal regions [47,48].
A final personality trait investigated in the present
study is Novelty Seeking. A low Novelty Seeking was
previously described as a characterizing personality
trait of PD patients [6]. Nevertheless, the present study,
just like other studies [40,41], did not find a differ-
ence between patients with PD and healthy participants
in Novelty Seeking. This might be explained by the
composition of the present sample. Tomer and Aharon-
Peretz [42] revealed that only patients with right onset
of the disease (i.e. motor symptoms initially presented
on the right side of the body) showed a low Novelty
Seeking, whereas only patients with a left onset of the
disease showed a high Harm Avoidance. Considering
that the present study found a high Harm Avoidance, it
might be possible that the majority of PD patients in-
cluded in this study had a left onset of the disease. This,
however, remains speculative since the side of disease
onset was not assessed. Another speculation for not
finding differences between groups regarding Novelty
Seeking might refer to the presence of impulsive com-
pulsive behaviors in PD patients. Impulsive compulsive
behaviors have been shown to be strongly associated
with high Novelty Seeking. Furthermore, these behav-
iors have been found in about 14% of patients with PD
treated with dopamine agonists [49,50]. Despite us try-
ing to exclude patients with co-morbidities including
impulsive compulsive behaviors, the possibility exist
that patients did not report these behaviors to the con-
sultant neurologist, in particular because these types of
problems are often hidden or unnoticed by patients [51].
Novelty Seeking was not found to be related with cog-
nitive impairments and emotional disturbances of PD
patients. It is difficult to discuss this finding, since a
non-significant result does not mean that there is no as-
sociation. One could assume that the selection of mea-
sures as applied in the present study did lack a sensitive
measure. In particular, a measure assessing reward and
punishment processing appears relevant since a study
on the effects of dopamine agonists reported associa-
tions between Novelty Seeking and reward learning as
well as punishment processing [43]. Therefore, future
studies on personality in PD should consider including
measures on reward and punishment processing.
A limitation of the present study was that PD pa-
tients were compared to healthy participants and not to
patients with other progressive degenerative disorders.
It is therefore not clear to what extent the results are
specific to PD.
In conclusion, the results of this study suggest that
cognition and emotion are selectively related to person-
ality traits in PD. Whereas Harm Avoidance covaries
with the emotional symptoms that can accompany PD,
Persistence and Reward dependence are related to cog-
nition in PD. Alterations in personality, cognition and
emotion in PD are thus not independent from each oth-
er.
References
[1] Koerts J, van Beilen M, Leenders KL, Brouwer WH, Tucha
L, Tucha O. Complaints about impairments in executive
functions in Parkinson’s disease: the association with neu-
ropsychological assessment. Parkinsonism Relat Disord 2012;
18(2): 194-197.
[2] Koerts J, Tucha L, Leenders KL, van Beilen M, Brouwer WH,
Tucha O. Subjective and objective assessment of executive
functions in Parkinson’s disease. J Neurol Sci 2011; 310(1–2):
172-175.
[3] Koerts J, Van Beilen M, Tucha O, Leenders KL, Brouwer
WH.Executive functioning in daily life in Parkinson’s disease:
initiative, planning and multi-task performance. PLoS One
2011; 6(12): e29254.
J. Koerts et al. / Neuropsychological and emotional correlates of personality traits in Parkinson’s disease 573
[4] Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive
profile of patients with newly diagnosed Parkinson disease.
Neurology 2005; 65(8): 1239-1245.
[5] Muslimovic D, Post B, Speelman JD, De Haan RJ, Schmand
B. Cognitive decline in Parkinson’s disease: a prospective
longitudinal study. J Int Neuropsychol Soc 2009; 15(3): 426-
437.
[6] Poletti M, Bonuccelli U. Personality traits in patients with
Parkinson’s disease: assessment and clinical implications. J
Neurol 2011; 17(6): 1158-62.
[7] Cloninger CR. A systematic method for clinical description
and classification of personality variants. A proposal. Arch
Gen Psychiatry 1987; 44(6): 573-588.
[8] Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological
model of temperament and character. Arch Gen Psychiatry
1993; 50(12): 975-990.
[9] Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fisch-
er JS. Neuropsychological Assessment. New York: Oxford
University Press; 2004.
[10] Fahn S, Elton RL, UPDRS program members. Unified Parkin-
sons DiseaseRating Scale. In: Fahn S, MarsdenCD, Goldstein
M, Calne DB, editors. Recent developments in Parkinsons dis-
ease Florham Park, NJ: Macmillan Healthcare Information;
1987; pp. 153-163.
[11] Hoehn MM, Yahr MD. Parkinsonism: onset, progression and
mortality. Neurology 1967; 17(5): 427-442.
[12] Esselink RA, de Bie RM, de Haan RJ. Unilateral pallidoto-
my versus bilateral subthalamic nucleus stimulation in PD: a
randomized trial. Neurology 2004; 62(2): 201-207.
[13] Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”.
A practical method for grading the cognitive state of patients
for the clinician. J Psychiatr Res 1975; 12(3): 189-198.
[14] Leentjens AF, Verhey FR, Lousberg R, Spitsbergen H,
Wilmink FW. The validity of the Hamilton and Montgomery-
Asberg depression rating scales as screening and diagnostic
tools for depression in Parkinson’s disease. Int J Geriatr Psy-
chiatry 2000; 15(7): 644-649.
[15] Duijsens IJ, Goekoop JG, Spinhoven P. Temperatment en
Karakter Vragenlijst (TCI). Datec; 2004.
[16] Montgomery SA, Asberg M. A new depression scale designed
to be sensitive to change. Br J Psychiatry 1979; 134: 382-389.
[17] Hammes JGW. De Stroop-kleur-woord test handleiding. Am-
sterdam; 1978.
[18] Reitan RM. Validity of the Trail Making Test as an indicator
of organic braindamage. Percptual and Motor Skills 1958; 8:
271-276.
[19] Flowers KA, Robertson C. The effect of Parkinson’s disease
on the ability to maintain a mental set. Journal of Neurology,
Neurosurgery & Psychiatry 1985; 48(6): 517-529.
[20] Wechsler D. Wechsler Memory Scale – Revised: The Psycho-
logical Corporation; 1987.
[21] Luteijn F, Barelds DPH. Groninger Intelligentie Test 2. Har-
court Test Publishers; 2004.
[22] Schmand B, Groenink SC, van den DM. [Letterfluency: psy-
chometric properties and Dutch normative data]. Tijdschr
Gerontol Geriatr 2008; 39(2): 64-76.
[23] Benton A, deHamser K. Multilingual aphasia examination.
Iowa City: University of Iowa; 1976.
[24] Wilson BA, Alderman N, Burgess P, Emslie H, Evans JJ.
Behavioural Assessment of the Dysexecutive syndrome. Bury
St. Edmunds, Suffolk: Thames Valley Test Company; 1996.
[25] DuboisB, SlachevskyA, Litvan I, PillonB. The FAB: a Frontal
Assessment Battery at bedside. Neurology 2000; 55(11):
1621-1626.
[26] Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D,
Petersen RC, et al. Diagnostic criteria for mild cognitive im-
pairment in Parkinson’s disease: Movement Disorder Society
Task Force guidelines. Mov Disord 2012; 27(3): 349-356.
[27] Sollberger M, Stanley CM, Ketelle R, Beckman V, Growdon
M, Jang J, et al. Neuropsychological correlates of dominance,
warmth, and extraversion in neurodegenerative disease. Cortex
2012; 48(6): 674-682.
[28] Koerts J, Leenders KL, Koning M, Portman AT, van BM.
Striatal dopaminergic activity (FDOPA-PET) associated with
cognitive items of a depression scale (MADRS) in Parkinson’s
disease. Eur J Neurosci 2007; 25(10): 3132-3136.
[29] Koerts J, Leenders KL, Koning M, Bouma A, van BM. The
assessment of depression in Parkinson’s disease. Eur J Neurol
2008; 15(5): 487-492.
[30] Brown RG, Landau S, Hindle JV, Playfer J, Samuel M, Wilson
KC, et al. Depression and anxiety related subtypes in Parkin-
son’s disease. J Neurol Neurosurg Psychiatry 2011; 82(7):
803-809.
[31] AarslandD, Pahlhagen S, BallardCG, EhrtU, Svenningsson P.
Depression in Parkinson disease – epidemiology, mechanisms
and management. Nat Rev Neurol 2011; 8(1): 35-47.
[32] Damholdt MF, Ostergaard K, Borghammer P, Larsen L. The
parkinsonian personality and concomitant depression. J Neu-
ropsychiatry Clin Neurosci 2011; 23(1): 48-55.
[33] Menza MA, Mark MH. Parkinson’s disease and depression:
the relationship to disability and personality. J Neuropsychia-
try Clin Neurosci 1994; 6(2): 165-169.
[34] Ono Y, Ando J, Onoda N, Yoshimura K, Momose T, Hirano
M, et al. Dimensions of temperament as vulnerability factors
in depression. Mol Psychiatry 2002; 7(9): 948-953.
[35] Cheung G, Todd-Oldehaver C. Personality trait of harm avoid-
ance in late-life depression. Int J Geriatr Psychiatry 2006;
21(2): 192-193.
[36] Nyman E, Miettunen J, Freimer N, Joukamaa M, Maki P,
Ekelund J, et al. Impact of temperament on depression and
anxiety symptoms and depressive disorder in a population-
based birth cohort. J Affect Disord 2011; 131(1–3): 393-397.
[37] Rihmer Z, Akiskal KK, Rihmer A, Akiskal HS. Current re-
search on affective temperaments. Curr Opin Psychiatry 2010;
23(1): 12-18.
[38] Richard IH, McDermott MP, Kurlan R, Lyness JM, Como
PG, Pearson N, et al. A randomized, double-blind, placebo-
controlled trial of antidepressants in Parkinson disease. Neu-
rology 2012; 78(16): 1229-1236.
[39] Leentjens AF, Van den AM, Metsemakers JF, Lousberg R,
VerheyFR.Higher incidence of depression preceding the onset
of Parkinson’s disease: a register study. Mov Disord 2003;
18(4): 414-418.
[40] McNamara P, Durso R, Harris E. Alterations of the sense
of self and personality in Parkinson’s disease. Int J Geriatr
Psychiatry 2008; 23(1): 79-84.
[41] McNamara P, Durso R, Harris E. “Machiavellianism” and
frontal dysfunction: evidence from Parkinson’s disease. Cogn
Neuropsychiatry 2007; 12(4): 285-300.
[42] Tomer R, Aharon-Peretz J. Novelty seeking and harm avoid-
ance in Parkinson’s disease: effects of asymmetric dopamine
deficiency. J Neurol Neurosurg Psychiatry 2004; 75(7): 972-
975.
[43] Bodi N, Keri S, Nagy H, Moustafa A, Myers CE, Daw N,
et al. Reward-learning and the novelty-seeking personality: a
between- and within-subjects study of the effects of dopamine
agonists on young Parkinson’s patients. Brain 2009; 132(Pt
9): 2385-2395.
574 J. Koerts et al. / Neuropsychological and emotional correlates of personality traits in Parkinson’s disease
[44] Cloninger CR, Zohar AH, Hirschmann S, Dahan D. The psy-
chological costs and benefits of being highly persistent: per-
sonality profiles distinguish mood disorders from anxiety dis-
orders. J Affect Disord 2012; 136(3): 758-766.
[45] Monchi O, Petrides M, Petre V, Worsley K,Dagher A. Wiscon-
sin Card Sorting revisited: distinct neural circuits participating
in different stages of the task identified by event-related func-
tional magnetic resonance imaging. J Neurosci 2001; 21(19):
7733-7741.
[46] Monchi O, Petrides M, Doyon J, Postuma RB, Worsley K,
Dagher A. Neural bases of set-shifting deficits in Parkinson’s
disease. J Neurosci 2004; 24(3): 702-710.
[47] Cohen MX, Schoene-Bake JC, Elger CE, Weber B.
Connectivity-based segregation of the human striatum predicts
personality characteristics. Nat Neurosci 2009; 12(1): 32-34.
[48] Bjornebekk A, Westlye LT, Fjell AM, Grydeland H, Walhovd
KB. Social Reward Dependence and Brain White Matter Mi-
crostructure. Cereb Cortex 2011 Dec 8.
[49] Poletti M, Bonuccelli U. Impulse control disorders in Parkin-
son’ disease: the role of personality and cognitive status. J
Neurol 2012 Apr 25.
[50] Voon V, Mehta AR, Hallett M. Impulse control disorders in
Parkinson’s disease: recent advances. Curr Opin Neurol 2011;
24(4): 324-330.
[51] Voon V, Potenza MN, Thomsen T. Medication-related impulse
control and repetitive behaviors in Parkinson’s disease. Curr
Opin Neurol 2007; 20(4): 484-492.



















































 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
